G5 Artikkeliväitöskirja
Splanchnic Metabolism and Blood Flow In Man. PET Studies with Reference to Obesity and Diabetes
Tekijät: Honka Henri
Kustantaja: University of Turku
Kustannuspaikka: Turku
Julkaisuvuosi: 2016
ISBN: ISBN 978-951-29-6640-0
eISBN: ISBN 978-951-29-6641-7
Verkko-osoite: http://urn.fi/URN:ISBN:978-951-29-6641-7
Rinnakkaistallenteen osoite: http://www.doria.fi/handle/10024/127331
Splanchnic region comprises the interaction of multiple organs, 
hormones and neural factors and is a critical regulator of 
glucose homeostasis during both postabsorptive and absorptive 
states. While splanchnic functions deteriorate during 
long-standing obesity predisposing to impaired glucose regulation 
and type 2 diabetes, many of the aspects of splanchnic metabolism 
and blood flow (BF) in health and disease are still unknown. 
In the present work, validation of positron emission 
tomography (PET) for the measurement of pancreatic and intestinal 
metabolism and BF in vivo was carried out and thereafter the method 
was applied to a total of 62 morbidly obese and 40 healthy 
individuals. In a set of cross-sectional and longitudinal studies 
glycemic control and β-cell function, splanchnic glucose and lipid 
metabolism, and splanchnic vascular responses to a mixed-meal, incretin
 infusions and glucose loading were explored before and after 
bariatric surgery and weight loss. 
Compared to healthy controls, pancreatic fatty acid (FA) 
uptake and steatosis were markedly increased in obese patients 
whereas pancreatic glucose uptake (GU) and BF were impaired. Elevated 
pancreatic steatosis and inadequate BF were associated with poor
 insulin secretion rate. In the small intestine, insulin upregulated GU 
nearly three-fold over the fasting values in healthy controls 
whereas normally glucose tolerant obese patients were unresponsive 
to the stimulatory effect of insulin. In lean controls and patients with
 type 2 diabetes, mixed-meal increased both pancreatic and 
intestinal BF, whereas GIP infusion decreased and increased 
pancreatic and intestinal BF, respectively. Bariatric surgery was 
followed by a prominent weight loss, increase in insulin sensitivity and
 β-cell function, and decrease in pancreatic FA uptake, rate of 
 steatosis and BF. While the vascular responses of GIP were 
essentially similar at post-surgery when compared to pre-surgery, 
splanchnic vascular responses during mixed-meal were enchanced, 
likely as a result of rapid gastric emptying. 
In conclusion, pancreatic and small intestinal metabolism and
 BF respond to obesity and type 2 diabetes, and to metabolic changes
 elicited by bariatric surgery. The adequacy of pancreatic BF responses 
and insulin-dependence of intestinal GU are pivotal concepts in the 
regulation of glucose homeostasis in humans. Obesity influences 
both of these physiological concepts, whereas altered gastrointestinal
 anatomy, incretins responses and weight loss after bariatric surgery 
are able to reverse these obesity-induced perturbations leading to 
improved glucose homeostasis. 
